All stock lists
IGC Pharma, Inc. (New York Stock Exchange Arca:IGC)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.25+0.00 (+0.45%)
Insider Score
––Not scored
IGC Insider Score
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
IGC Stock Insider Trading Activity
IGC stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mukunda Ram CEO | Gift | 100,000 | — | — | 1.5% | 6,775,563 | Sep 25, 2026 | — | Form 4 |
| Mukunda Ram CEO | Gift | 100,000 | — | — | 1.5% | 6,675,563 | Sep 25, 2026 | — | Form 4 |
| GRIMALDI CLAUDIA Director | Gift | 150,000 | — | — | 4.4% | 3,271,092 | Sep 25, 2026 | — | Form 4 |
| Mukunda Ram CEO | Award | 2,226,475 | $0.27 | $601.15K | 47.9% | 6,875,563 | Jun 30, 2026 | — | Form 4 |
| GRIMALDI CLAUDIA Director | Award | 2,048,378 | $0.27 | $553.06K | 149% | 3,421,092 | Jun 30, 2026 | — | Form 4 |
| PRINS RICHARD K Director | Option exercise | 100,000 | — | — | 7.3% | 1,471,251 | Apr 1, 2026 | — | Form 4 |
| PRINS RICHARD K Director | Option exercise | 70,000 | — | — | 4.8% | 1,541,251 | Apr 1, 2026 | — | Form 4 |
| Mukunda Ram CEO | Option exercise | 333,333 | — | — | 8.3% | 4,326,011 | Apr 1, 2026 | — | Form 4 |
| Mukunda Ram CEO | Option exercise | 323,077 | $0.26 | $84.00K | 7.5% | 4,649,088 | Apr 1, 2026 | — | Form 4 |
| Mukunda Ram CEO | Option exercise | 16,667 | — | — | 1.9% | 877,419 | Apr 1, 2026 | — | Form 4 |
| Mukunda Ram CEO | Option exercise | 33,332 | — | — | 3.8% | 910,751 | Apr 1, 2026 | — | Form 4 |
| Moran James P Director | Option exercise | 80,000 | — | — | 7.2% | 1,185,735 | Apr 1, 2026 | — | Form 4 |
| Moran James P Director | Option exercise | 50,000 | — | — | 4.2% | 1,235,735 | Apr 1, 2026 | — | Form 4 |
| GRIMALDI CLAUDIA Director | Option exercise | 100,000 | — | — | 8.8% | 1,234,252 | Apr 1, 2026 | — | Form 4 |
| GRIMALDI CLAUDIA Director | Option exercise | 138,462 | $0.26 | $36.00K | 11.2% | 1,372,714 | Apr 1, 2026 | — | Form 4 |
| Mukunda Ram CEO | Option exercise | 50,000 | — | — | 6.2% | 860,752 | Feb 3, 2026 | — | Form 4 |
| PRINS RICHARD K Director | Option exercise | 100,000 | — | — | 7.9% | 1,371,251 | Jan 19, 2026 | — | Form 4 |
| GRIMALDI CLAUDIA Director | Gift | 50,000 | — | — | 4.2% | 1,134,252 | Oct 17, 2025 | — | Form 4 |
| Mukunda Ram CEO | Gift | 100,000 | — | — | 2.4% | 3,992,678 | Oct 17, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Award (A) — Grant or award from the company, not a purchase
- Option exercise (M) — Exercise or conversion of an exempt derivative
- Gift (G) — Bona fide gift
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.